Showing posts with label BPY. Show all posts
Showing posts with label BPY. Show all posts

November 13, 2020

Notable Analyst Upgrades and Downgrades for Week of November 9, 2020

 


Upgrades:

 


C.H. Robinson Worldwide (NASDAQ:CHRW) was upgraded by research analysts at Smith Barney Citigroup from a "neutral" rating to a "buy" rating in a research report issued to clients and investors on Monday, The Fly reports. The brokerage presently has a $118.00 target price on the transportation company's stock, up from their prior target price of $100.00. Smith Barney Citigroup's target price indicates a potential upside of 26.00% from the company's previous close.

CHRW has been the subject of a number of other reports. Barclays raised C.H. Robinson Worldwide from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $95.00 to $115.00 in a research report on Friday, October 16th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised C.H. Robinson Worldwide from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $100.00 to $118.00 in a research report on Monday. Stifel Nicolaus downgraded C.H. Robinson Worldwide from a "buy" rating to a "hold" rating and boosted their price objective for the stock from $79.00 to $94.00 in a research report on Thursday, July 30th. They noted that the move was a valuation call. Stephens downgraded C.H. Robinson Worldwide from an "overweight" rating to an "equal weight" rating and lowered their price objective for the stock from $110.00 to $95.00 in a research report on Thursday, October 29th. Finally, Loop Capital downgraded C.H. Robinson Worldwide from a "buy" rating to a "hold" rating and set a $96.00 price objective for the company. in a research report on Thursday, July 30th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of "Hold" and a consensus target price of $90.67. Read more …

 


Albemarle (NYSE:ALB) was upgraded by equities research analysts at Smith Barney Citigroup from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Monday, The Fly reports. The firm presently has a $132.00 price objective on the specialty chemicals company’s stock, up from their prior price objective of $99.00. Smith Barney Citigroup’s target price would suggest a potential upside of 13.53% from the company’s current price.

Several other brokerages also recently weighed in on ALB. KeyCorp increased their target price on shares of Albemarle from $60.00 to $89.00 and gave the company an “underweight” rating in a research note on Friday. Berenberg Bank downgraded shares of Albemarle from a “hold” rating to a “sell” rating and increased their target price for the company from $65.00 to $68.00 in a research note on Monday, July 27th. Jefferies Financial Group increased their target price on shares of Albemarle from $81.00 to $100.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. BMO Capital Markets raised their price target on shares of Albemarle from $115.00 to $120.00 and gave the stock an “outperform” rating in a research note on Friday. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised shares of Albemarle from a “neutral” rating to a “buy” rating and raised their price target for the stock from $99.00 to $132.00 in a research note on Monday. Six research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $92.54. Read more …

 


Ventas (NYSE:VTR) was upgraded by stock analysts at Jefferies Financial Group from an “underperform” rating to a “hold” rating in a note issued to investors on Tuesday, Briefing.com reports. The brokerage presently has a $50.00 price target on the real estate investment trust’s stock. Jefferies Financial Group’s target price points to a potential upside of 6.72% from the company’s current price.

Several other equities analysts have also recently issued reports on the stock. Morgan Stanley upped their target price on shares of Ventas from $36.00 to $39.00 and gave the company an “equal weight” rating in a research note on Thursday, September 17th. Royal Bank of Canada upgraded shares of Ventas from a “sector perform” rating to an “outperform” rating and upped their target price for the company from $34.00 to $45.00 in a research note on Friday, August 14th. Barclays upped their target price on shares of Ventas from $37.00 to $42.00 and gave the company an “equal weight” rating in a research note on Wednesday, September 16th. Argus cut shares of Ventas from a “buy” rating to a “hold” rating in a research note on Tuesday, September 8th. Finally, Stifel Nicolaus restated a “hold” rating and set a $43.00 target price on shares of Ventas in a research note on Tuesday, September 1st. Five investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $39.31. Read more …

 

 


Chubb (NYSE:CB) was upgraded by The Goldman Sachs Group from a “sell” rating to a “buy” rating in a research note issued on Tuesday, Briefing.com reports. The brokerage presently has a $163.00 price target on the financial services provider’s stock, up from their previous price target of $120.00. The Goldman Sachs Group’s price objective would suggest a potential upside of 10.90% from the company’s current price.

Several other research firms also recently weighed in on CB. William Blair upgraded Chubb from an “underperform” rating to a “market perform” rating in a research report on Monday, July 20th. Bank of America upgraded Chubb from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $123.00 to $132.00 in a report on Thursday, October 29th. They noted that the move was a valuation call. Zacks Investment Research downgraded Chubb from a “hold” rating to a “strong sell” rating and set a $97.00 price objective for the company. in a report on Wednesday, September 30th. JPMorgan Chase & Co. upgraded Chubb from a “neutral” rating to an “overweight” rating and set a $152.00 price objective for the company in a report on Monday, October 12th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Chubb from $135.00 to $136.00 and gave the company a “hold” rating in a report on Thursday, October 29th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $145.31. Read more …

 

February 15, 2017

4 High-Yield Dividend Stocks You Don't Have to Babysit

Looking for a top-notch income stock to buy and hold? Our team of Fools thinks you should give these four companies a closer look.



Most income investors are naturally drawn to the stocks that offer up high yields. That's understandable, but oftentimes, a market-topping yield can be a sign that a business is in trouble. For that reason, investors need to be picky about which dividend stocks they choose to buy.

To aid you in your search, we asked a team of Fools to share a high-yield stock they think is a great buy-and-hold candidate. Read on to see why they highlighted Philip Morris International (NYSE:PM), Brookfield Property Partners (NYSE:BPY), Pfizer (NYSE:PFE), NextEra Energy Partners (NYSE:NEP).